Right prescription

Amid-size Indian pharmaceutical company called Strides Arcolab has sold its business of making branded generic drugs in Asia and Australia, to an Australian company. At Rs 1,965 crore, the deal fetches Strides three and a half times as much money as it invested in the entity within four years - a staggering return by any yardstick. Naysayers will seize this deal - as they seized upon the sale of Ranbaxy and Piramal Healthcare - to moan about yet another Indian sellout to Big Pharma. 

Read Full Story>>